Professor Timothy Hughes is the Clinical Director in the Precision Cancer Medicine Theme at SAHMRI and Consultant Haematologist at the Royal Adelaide Hospital. He is also Clinical Professor at the University of Adelaide, Inaugural Fellow of the AAHMS and Fellow of the Australian Academy of Science.

Dr Liesl Butler is a dual-trained haematologist working in Peter MacCallum Cancer Centre Pathology. She has a clinical and research interest in myeloproliferative neoplasms and their genomics, having completed a PhD in this area and a molecular haematopathology fellowship. Her research has been recognised with the Albert Baikie Memorial Medal.

Dr Ng is a clinical and laboratory haematologist at Royal Perth Hospital with subspecialist interest in myeloproliferative neoplasms following a UK fellowship. Her interests span clinical trials, clinical and translational research and patient advocacy. Dr Ng has spoken and chaired sessions at national and international meetings and authored numerous publications.

Peter is Professor of Pathology in the Department of Molecular Medicine and Pathology, University of Auckland School of Medicine and a consulltant haematologist in the Department of Haematology, Auckland City Hospital. He is Director of the Blood Cancer NZ Research Unit and the lead for clinical research in the Department of Haematology, Auckland City Hospital . His clinical and research interests include leukaemia biology and genomics, and improving therapy and outcomes for patients with myeloid and other blood cancers.

A/Prof Agnes Yong is a dual-trained haematologist and transplant physician and obtained her PhD on chronic myeloid leukaemia from Imperial College London. Following post-doctoral research at the NIH in graft-versus-leukaemia, she moved to Australia and is Consultant Haematologist at the Royal Perth Hospital. She is a recipient of multiple research grants, with publications in chronic myeloid leukaemia, transplantation and immunotherapy, including chimeric antigen receptor (CAR) T-cell therapy.